Please assess the completion status of the following clinical trial:

Trial Title: Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~COHORT A:~* Eligible patients to be randomized for the iMPACT study must:~  1. Carry a diagnosis of cancer~ 2. Patient is considered potentially eligible for a cancer therapeutic clinical trial (TCT) and is being offered an opportunity to sign an informed consent document for the cancer TCT~* Eligible patients to receive FRP (these documents will be requested by Lazarex Foundation, however research coordinator at site can help patient collect documents):~  1. Have a household income =\< 700% of the 2018 Health and Human Services (HHS) Poverty Guidelines~ 2. Willing to provide proof of household income. Acceptable proof of income documents are: first two pages of signed copy of income tax return, or if a return is not filed, a copy of the most recent pay stub, unemployment check, Supplemental Security Income (SSI), Social Security Disability (SSD), or public assistance benefit notification. If a patient is not employed, they must submit a signed letter stating their current financial situation

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort A : Usual Care (FRP Only) (Type: ACTIVE_COMPARATOR): Patients or parents/legal guardians of patients receive FRP brochure at the time of iMPACT consent.
- Cohort A: Usual Care + Intervention (FRP + Follow-up) (Type: EXPERIMENTAL): Patients or parents/legal guardians of patients receive FRP brochure at the time of iMPACT consent and a follow-up phone call on day 3 after iMPACT consent.

Based on this trial design, predict the completion outcome and termination type (if applicable).